Ctic after market
WebIdeas. CTI Short Trade Opportunity NASDAQ:CTIC -EMA21 cross below EMA 50 -Price breached support level 1 -Price breached support level 2 -Price below Daily SMA 200 -Target: $3.50 -R/R- 1.5 -Radar: Possible … Web1 day ago · Get a real-time CTI BioPharma Corp. (CTIC) stock price quote with breaking news, financials, statistics, charts and more. ... Financial Performance. Financial Statements. Analyst Forecast. According to 15 analysts, the average rating for CTIC …
Ctic after market
Did you know?
WebMar 30, 2024 · Let’s start up with the current stock price of CTI BioPharma Corp. (CTIC), which is $4.44 to be very precise. The Stock rose vividly during the last session to $4.525 after opening rate of $4.40 while the lowest price it went was recorded $4.39 before … WebCTIC : 4.09 (-0.24%) CTI BioPharma to Present at the 43rd Annual Cowen Health Care Conference PR Newswire - Wed Mar 1, 3:20PM CST. /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the …
Web20 hours ago · A value under 20 is generally considered good. CTIC 4.40 +0.18 (4.27%) Will CTIC be a Portfolio Killer in April? Zacks Investment Research is releasing its prediction for CTIC based on the... WebCTIC 3.05% DJIA 0.29% Russell 2K 0.80% Health Care/Life Sciences -0.35% Overview Per-Share Earnings, Actuals & Estimates CTI BioPharma Corp. Quarterly Annual …
WebApr 10, 2024 · See the latest CTI BioPharma Corp stock price (NASDAQ:CTIC), related news, valuation, dividends and more to help you make your investing decisions. WebCTI BioPharma Corp. (CTIC) has a Smart Score of 6 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except ...
WebNAS :CTIC (USA) Portfolio $ 4.33 -0.07 (-1.59%) 11:08 PM EST Warning! GuruFocus has detected 5 Severe warning signs with CTIC. Get your 7-Day Free Trial to check it out. Also Trade In: Volume: 3.47M Market Cap $: 570.85M PE Ratio: At Loss Avg Vol (2M): 3.06M Enterprise Value $: 540.87M PB Ratio: 0 GF Score: Year: 10Y: -% Above Low: +NaN%
Web2 days ago · The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential. Weaknesses Low profitability weakens the company. The valuation of the company is particularly high given the cash flows generated by its activity. phonetrack androidWebMar 23, 2024 · The stock current value is $4.31.Recently in News on March At the end of the latest market close, CTI BioPharma Corp. (CTIC) was valued at $4.30. In that particular session, Stock kicked-off at the price of $4.45 while reaching the peak value of $4.49 and lowest value recorded on the day was $4.28. how do you throw a slider in baseballWebApr 12, 2024 · The price of CTIC decreased -2.80% over the last 30 days. And in the last five days, it has surged by 6.23%. CTI BioPharma Corp. (CTIC) current stock price is $4.34. During the last trading session, the stock soared, reaching $4.42 after opening at $4.27. … how do you throw away a microwaveWebCTIC Stock Price - CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating phonetrack cnpjWebApr 10, 2024 · The latest price target for CTI BioPharma ( NASDAQ: CTIC) was reported by JMP Securities on March 7, 2024. The analyst firm set a price target for $9.00 expecting CTIC to rise to within 12... phonetrack nextcloudWebMar 29, 2024 · Posted by Mar 29th, 2024. CTI BioPharma Corp. ( NASDAQ:CTIC – Get Rating )’s share price was up 4.4% on Monday . The company traded as high as $4.49 and last traded at $4.49. Approximately 869,000 shares traded hands during mid-day trading, a decline of 71% from the average daily volume of 3,020,629 shares. The stock had … phonetrack отзывыWebOn Mar 06, 2024, Cti Biopharma ( NASDAQ: CTIC) reported Q4 2024 earnings per share (EPS) of -$0.12, up 69.23% year over year. Total Cti Biopharma earnings for the quarter were -$17.46 million. In the same quarter last year, Cti Biopharma 's earnings per share … how do you throw a slurve